Evidence map›Paper›PMID 1291231›Full record

ArticleChromosoma1992

Control of DNA synthesis genes in budding yeast: involvement of the transcriptional modulator MOT1 in the expression of the DNA polymerase alpha gene.

S Piatti, R Tazzi, A Pizzagalli, P Plevani, G Lucchini

Abstract read
PubMed Publisher
In one paragraph

Article in Chromosoma, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mot1 activates and represses transcription by direct, ATPase-dependent mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  6. Article
  7. Article
  8. Article
  9. Molecular genetics of the RNA polymerase II general transcriptional machinery.Microbiology and molecular biology reviews : MMBR · 1998
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S PiattiDipartimento di Genetica e di Biologia dei Microrganismi, Università degli Studi di Milano, Italy.
R Tazzi
A Pizzagalli
P Plevani
G Lucchini
University of Milan · ITUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodic transcription during the cell cycle of the budding yeast DNA polymerase alpha gene (POL1) requires the cis-acting element 5' ACGCGT 3', which has been found in the 5' non-coding region of all the DNA synthesis genes analyzed so far. Search for trans-acting mutations affecting POL1 expression led to the isolation of the temperature-sensitive reg1033 mutant, that showed increased levels of both DNA polymerase alpha and delta gene transcripts. Cloning of the REG1033 gene demonstrated that it is essential for cell viability and required for proper expression of the POL1 gene. DNA sequence comparison established that the REG1033 gene is identical to MOT1, a gene encoding a presumptive DNA helicase which modulates transcription of several yeast genes.

Indexed as

Base SequenceCell CycleCloning, MolecularDNA Polymerase IIDNA ReplicationGene Expression Regulation, EnzymologicGene Expression Regulation, FungalMolecular Sequence DataMutationSaccharomyces cerevisiaeTrans-ActivatorsDNA Polymerase IITrans-Activators

Identifiers

PMID1291231
OpenAlexW1983111250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.